October 25, 2016 3:37 AM ET


Company Overview of Accera, Inc.

Company Overview

Accera, Inc. is a clinical stage biotechnology company that develops therapies for central nervous system disorders. The company focuses on developing a pipeline of products targeting neurodegenerative conditions. Its proprietary scientific platform addresses unmet medical needs in brain health, including Alzheimer’s disease. The company was founded in 2001 and is based in Boulder, Colorado.

3005 Center Green Drive

Suite 205

Boulder, CO 80301

United States

Founded in 2001





Key Executives for Accera, Inc.

Chief Executive Officer and President
Age: 60
Chief Financial Officer
Age: 56
Chief Medical Officer
Vice President of Finance, Controller andSecretary
Compensation as of Fiscal Year 2016.

Accera, Inc. Key Developments

Accera Appoints Jeffrey Cummings and Bruno Vellas to its Scientific Advisory Board

Accera, Inc. announced the appointment of Jeffrey L. Cummings, M.D., Sc.D. and Bruno Vellas, M.D., Ph.D. to the company's Scientific Advisory Board. Dr. Cummings is the director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada and Cleveland, Ohio. He is the Camille and Larry Ruvo Chair of the Neurological Institute of Cleveland Clinic and Professor of Medicine (Neurology), Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Additionally, Dr. Cummings serves as the principal investigator and director of the Center for Neurodegeneration and Translational Neuroscience. Previously, Dr. Cummings was a professor of neurology and psychiatry at UCLA where he was also the director of the Mary S. Easton Center for Alzheimer's Disease Research and the director of the Deane F. Johnson Center for Neurotherapeutics. Dr. Cummings has authored or edited 39 books and published over 700 peer-reviewed papers. Dr. Vellas is the chairman of the Toulouse Gerontopole and the chief of the department of internal medicine and geriatrics at the Toulouse University Hospital. Additionally, he is the chief of the Alzheimer's Disease Clinical Research Centre at the University of Toulouse and a member of the INSERM (National Institute of Medical Research) 1027 Unit on Aging. Previously, Dr. Vellas served as president of the International Association of Gerontology and Geriatrics.

Accera, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016

Accera, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States. Presentation Date(s): Sep-09-2016.

Accera, Inc. Appoints C. Evan Ballantyne as Chief Financial Officer

Accera, Inc. announced the appointment of C. Evan Ballantyne as chief financial officer. Mr. Ballantyne joins Accera from Agenus, Inc. where he has been the chief financial officer.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Accera, Inc., please visit www.accerapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.